Facebook Linkedin Twitter
Inside Precision Medicine Trace Neuroscience Launches with $101M and a Potential Genomic ALS Target

Third Rock Ventures

Degradation of a motor neuron presented as an illustration. Shows the kind of damage seen in ALS, which may be worsened by alpha-5 integrin
News & Features

Trace Neuroscience Launches with $101M and a Potential Genomic ALS Target

0
CART Cell Cancer Immunotherapy
News & Features

Precision Immuno-Oncology Start-Up Clasp Launches with $150M and Vogelstein as Co-Founder

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine